26.02.2007 12:00:00
|
McKesson Acquires Practice Partner
McKesson Corporation (NYSE:MCK) today announced the acquisition of
Physician Micro Systems, Inc., known as Practice Partner, a leading
provider of integrated software for electronic health records (EHRs),
medical billing and appointment scheduling for independent physician
practices. Terms of the agreement were not disclosed. The acquisition,
along with recently acquired Per-Se Technologies, Inc., supports McKesson’s
commitment to provide a complete solution –
including software, billing and collection services, supplies and
connectivity – to physician practices
regardless of size, specialty or geographic location.
"We’ve built strong
momentum with our Connecting PhysiciansSM
strategy, which is focused on helping hospitals to reduce traditional
EHR adoption barriers by collaborating with local physician practices to
provide a single record for inpatient and ambulatory care,”
said Pamela Pure, president, McKesson Provider Technologies. "With
Practice Partner, McKesson is now positioned to automate independent
physician offices and to deploy EHR technology to help drive safer, more
efficient care.”
Practice Partner has achieved strong market success by developing a
comprehensive set of clinical and administrative tools that improve
patient care while streamlining practice management for small to
mid-sized independent medical practices. The Practice Partner solution
includes an electronic health record system certified by the
Certification Commission for Healthcare Information Technology (CCHITSM);
a sophisticated multi-clinic scheduler; and a comprehensive practice
management system. Practice Partner’s customer
base includes more than 1,500 practices representing approximately 6,000
physicians.
"Joining McKesson is an important step in
Practice Partner’s evolution and strategy for
rapid growth,” said Andrew G. Ury, M.D.,
founder and CEO of Practice Partner. "As part
of the world’s largest healthcare services
company, we can extend our reach to help even more physicians in
independent practices increase productivity and improve quality of care.”
Through its Connecting PhysiciansSM strategy,
McKesson will continue to maintain a strong focus on hospitals that wish
to partner with physician practices in creating an integrated healthcare
community. As the centerpiece of Connecting Physicians, Horizon
Ambulatory Care™ provides hospitals and
medical groups with a single, secure online patient record flowing
across care settings. The addition of the Practice Partner solution
provides McKesson with a strong, powerful offering for the independent
physician segment.
"McKesson now has a technology footprint with
20 percent of the nation’s physicians,”
said Pure. "Our comprehensive portfolio is
designed to satisfy the diverse requirements of physician practices of
every size and specialty, giving them one-stop shopping with the backing
of a Fortune 16 leader in healthcare.”
McKesson’s comprehensive array of physician
practice solutions includes:
CCHIT-certified electronic health records to automate clinical
practice. McKesson’s Horizon Ambulatory Care™
Release 9.4 and Practice Partner Patient Records 9.1 are certified and
meet CCHIT ambulatory EHR criteria for 2006.
RelayHealth connectivity solutions that make it possible for
physicians to seamlessly interact with other physicians and providers
as well as patients, payors and retail pharmacies
Practice management solutions that streamline registration, scheduling
and billing
Revenue cycle outsourcing services that improve collections, cash flow
and business office productivity
Medical imaging solutions to capture, retrieve, view and store
diagnostic images
Medical-surgical equipment and supplies
Risk Factors
Except for historical information contained in this press release,
matters discussed may constitute "forward-looking
statements”, within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, that involve risks and uncertainties that could
cause actual results to differ materially from those projected,
anticipated or implied. These statements may be identified by their use
of forward-looking terminology such as "believes”,
"expects”, "anticipates”,
"may”, "should”,
"seeks”, "approximates”,
"intends”, "plans”,
"estimates” or the
negative of these words or other comparable terminology. The most
significant of these risks and uncertainties are described in the company’s
Form 10-K, Form 10-Q and Form 8-K reports filed with the Securities and
Exchange Commission and include, but are not limited to: adverse
resolution of pending shareholder litigation regarding the 1999
restatement of our historical financial statements; the changing U.S.
healthcare environment, including changes in government regulations and
the impact of potential future mandated benefits; competition; changes
in private and governmental reimbursement or in the delivery systems for
healthcare products and services; governmental and manufacturers’
efforts to regulate or control the pharmaceutical supply chain; changes
in pharmaceutical and medical-surgical manufacturers’
pricing, selling, inventory, distribution or supply policies or
practices; changes in the availability or pricing of generic drugs;
changes in customer mix; substantial defaults in payment or a material
reduction in purchases by large customers; challenges in integrating and
implementing the company’s internally used or
externally sold software and software systems, or the slowing or
deferral of demand or extension of the sales cycle for external software
products; continued access to third-party licenses for software and the
patent positions of the company’s proprietary
software; the company’s ability to meet
performance requirements in its disease management programs; the
adequacy of insurance to cover liability or loss claims; new or revised
tax legislation; foreign currency fluctuations or disruptions to foreign
operations; the company’s ability to
successfully identify, consummate and integrate strategic acquisitions;
changes in generally accepted accounting principles (GAAP) and general
economic conditions. The reader should not place undue reliance on
forward-looking statements, which speak only as of the date they are
made. The company assumes no obligation to update or revise any such
statements, whether as a result of new information or otherwise.
About McKesson
McKesson Corporation, currently ranked 16th on the FORTUNE 500, is a
healthcare services and information technology company dedicated to
helping its customers deliver high-quality healthcare by reducing costs,
streamlining processes, and improving the quality and safety of patient
care. Over the course of its 174-year history, McKesson has grown by
providing pharmaceutical and medical-surgical supply management across
the spectrum of care; healthcare information technology for hospitals,
physicians, homecare, and payors; hospital and retail pharmacy
automation; and services for manufacturers and payors designed to
improve outcomes for patients. For more information: http://www.mckesson.com.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu McKesson Corp.mehr Nachrichten
02.12.24 |
S&P 500-Wert McKesson-Aktie: So viel Gewinn hätte eine Investition in McKesson von vor 5 Jahren abgeworfen (finanzen.at) | |
25.11.24 |
S&P 500-Wert McKesson-Aktie: So viel hätten Anleger mit einem Investment in McKesson von vor 3 Jahren verdient (finanzen.at) | |
18.11.24 |
S&P 500-Titel McKesson-Aktie: So viel Gewinn hätte ein McKesson-Investment von vor einem Jahr eingefahren (finanzen.at) | |
11.11.24 |
S&P 500-Papier McKesson-Aktie: So viel hätte eine Investition in McKesson von vor 10 Jahren abgeworfen (finanzen.at) | |
07.11.24 |
S&P 500-Handel aktuell: S&P 500 steigt nachmittags (finanzen.at) | |
07.11.24 |
Donnerstagshandel in New York: So steht der S&P 500 mittags (finanzen.at) | |
05.11.24 |
Ausblick: McKesson legt Quartalsergebnis vor (finanzen.net) | |
04.11.24 |
S&P 500-Titel McKesson-Aktie: So viel hätte eine Investition in McKesson von vor 5 Jahren abgeworfen (finanzen.at) |
Analysen zu McKesson Corp.mehr Analysen
Aktien in diesem Artikel
McKesson Corp. | 588,80 | -0,41% |
Indizes in diesem Artikel
S&P 500 | 6 049,88 | 0,05% |